123
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Clinical Characteristics, Treatment Patterns and Economic Burden of COPD in Kyrgyzstan: A FRESH AIR Study

ORCID Icon, , , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 2833-2843 | Published online: 11 Oct 2021

References

  • World Health Organization. Chronic obstructive pulmonary disease. WHO Fact Sheets; 2017.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • Institute for Health Metrics and Evaluation. GBD compare data visualization. Kyrgyzstan; 2017.
  • Tabyshova A, Emilov B, Postma MJ, Chavannes NH, Sooronbaev T, van Boven JFM. Prevalence and economic burden of respiratory diseases in central Asia and Russia: a systematic review. Int J Environ Res Public Health. 2020;17(20):7483. doi:10.3390/ijerph17207483
  • National Statistical Committee of the Kyrgyz Republic. The number of diseases by major disease groups; 2018.
  • Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364.
  • Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193. doi:10.1183/13993003.01193-2018
  • Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003;123(3):784–791. doi:10.1378/chest.123.3.784
  • Brakema EA, Tabyshova A, van der Kleij RMJJ, et al. FRESH AIR collaborators. The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study. Respir Res. 2019;20(21). doi:10.1186/s12931-019-1255-z
  • Ibraimova A, Akkazieva B, Ibraimob A, Manzhieva E, Rachel B. Kyrgyzstan. Health system overview. Health Syst Time Change. 2011;13(3):17.
  • Cragg L, Williams S, Chavannes NH, et al. FRESH AIR: an implementation research project funded through Horizon 2020 exploring the prevention, diagnosis and treatment of chronic respiratory diseases in low-resource settings. NPJ Primary Care Respir Med. 2016;26:1–5.
  • National Statistical Committee of the Kyrgyz Republic. Population of the Kyrgyz Republic; 2016.
  • van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:1–0.
  • Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(17). doi:10.1186/1751-0473-3-17
  • Arkhipov V, Arkhipova D, Miravitlles M, Lazarev A, Stukalina E. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial. Int J Chron Obstruct Pulmon Dis. 2017;12:3255.
  • Tashmetova GT, Liverko IV. Chronic obstructive pulmonary disease in organized groups. Tuberculosis Lung Dis. 2020;98(6):36–39. doi:10.21292/2075-1230-2020-98-6-36-39
  • American Cancer Society, Inc. and Vital Strategies. The tobacco atlas. Tobacco Atlas; 2015.
  • Roberts B, Gilmore A, Stickley A, et al. Changes in smoking prevalence in 8 countries of the former Soviet Union between 2001 and 2010. Am J Public Health. 2012;102(7):1320–1328. doi:10.2105/AJPH.2011.300547
  • Quirmbach D, Gerry CJ. Gender, education and Russia’s tobacco epidemic: a life-course approach. Soc Sci Med. 2016;160:54–66.
  • Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823–860.
  • Brakema EA, van Gemert FA, Williams S, et al; FRESH AIR collaborators. Implementing a context-driven awareness programme addressing household air pollution and tobacco: a FRESH AIR study. NPJ Prim Care Respir Med. 2020;30(1):1–8.
  • Dalal AA, Patel J, D’Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm. 2015;21(7):575–583.
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.00012408
  • Sicras-Mainar ANR. Cost of arterial hypertension according to levels of morbidity in primary care setting. Med Clin (Barc). 2009;133(8):290–295. doi:10.1016/j.medcli.2009.05.017
  • Kontsevaya AV, Mukaneyeva DK, Balanova YA, Khudyakov MB, Drapkina OM. Economic burden of respiratory diseases and chronic obstructive pulmonary disease in Russian Federation, 2016. Pulmonologiya. 2019;29(2):159–166. doi:10.18093/0869-0189-2019-29-2-159-166
  • Corsico AG, Braido F, Contoli M, et al. Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up. Respir Med. 2019;153:68–75.
  • Ministry of Health of the Republic of Uzbekistan and World Bank. Health effects of smoking population and economy of Uzbekistan; 2005.
  • Gaygol’nik TV, Demko IV, Bochanova EN, Bikulova TV, Kraposhina AY. Drug supplying management for patients with chronic obstructive pulmonary disease at Krasnoyarsk kray. Pulmonologiya. 2016;26(2):208–214.
  • Tabyshova A, Hurst JR, Soriano JB, et al. Gaps in COPD guidelines of low- and middle-income countries: a systematic scoping review. Chest. 2021;159(2):575–584. doi:10.1016/j.chest.2020.09.260
  • van Gemert F, de Jong C, Kirenga B, et al. Effects and acceptability of implementing improved cookstoves and heaters to reduce household air pollution: a FRESH AIR study. NPJ Prim Care Respir Med. 2019;29(1). doi:10.1038/s41533-019-0144-8
  • Anastasaki M, Trigoni M, Pantouvaki A, et al. Establishing a pulmonary rehabilitation programme in primary care in Greece: a FRESH AIR implementation study. Chron Respir Dis. 2019;16:156.
  • Papadakis S, Anastasaki M, Papadakaki M. ‘Very brief advice’ (VBA) on smoking in family practice: a qualitative evaluation of the tobacco user’s perspective. BMC Fam Pract. 2020;21(1). doi:10.1186/s12875-020-01195-w
  • Punekar YS, Shukla A, Müllerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. doi:10.2147/COPD.S54417
  • Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
  • Philip KE, Akylbekov A, Stambaeva B, Sooronbaev T, Jones R. Music, dance, and harmonicas for people with COPD. Respir Care. 2019;64(3):359. doi:10.4187/respcare.06701
  • Shen Y, Chang C, Zhang J, Jiang Y, Ni B, Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study. Environ Health Prev Med. 2017;22(1):19. doi:10.1186/s12199-017-0634-7
  • Kjærgaard J, Nissen TN, Isaeva E, et al.; FRESH AIR collaborators. No time for change? Impact of contextual factors on the effect of training primary care healthcare workers in Kyrgyzstan and Vietnam on how to manage asthma in children - A FRESH AIR implementation study. BMC Health Serv Res. 2020;20(1). doi:10.1186/s12913-020-05984-y